alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.2      Statement of Work with Pfizer Oncology eDetailing Program

                                 MEDIVISOR LOGO
                          The e-detailing solution...

                                                                January 25, 2005

STATEMENT OF WORK

Pfizer Oncology eDetailing Program:

Medivisor, Inc. agrees to provide the following services to Pfizer
Pharmaceuticals Oncology Division. This project will involve a preliminary pilot
program to be followed (provisionally) by two additional similar programs. The
brands to be covered are Camptosar, Aromasin and Ellence.

         o        Medivisor will closely coordinate its efforts on this project
                  with the other project vendors as identified by the program
                  coordinator. Wayne Wertheim will be appointed to interact on
                  Medivisor's behalf and partake as is necessary in all project
                  meetings, conference calls, reviews, etc.

         o        Medivisor will produce (for each brand) an animated (flash
                  type) presentation of approximately 5-9 minutes. This
                  presentation will be constructed using content supplied to
                  Medivisor by the brand agency of record on the project. Once
                  completed the presentation will be hosted on Mednet.

         o        Medivisor will provide its expertise in the formatting,
                  presentation, and execution of the programs, and will
                  coordinate all of the content, flash, and other related items
                  into its final presentation form.

         o        Medivisor will comply with presentation format requirements as
                  set forth by the Mednet agency of record.

         o        Medivisor will produce both a "hand-out" and email invitation
                  to the program. Separate brand specific invitations will be
                  produced for Camptosar, Aromasin and Ellence. Sufficient
                  quantities of the same will be provided to Pfizer for
                  distribution.

         o        Medivisor will provide all documentation necessary to fulfill
                  regulatory compliance in accordance will Pfizer policies.


                                       1
<PAGE>

PROGRAM PRICE: $50 - 60,000

(Note: Pricing is for all three brand projects. Each project will be billed per
brand project at a rate of 1/3 the total program price.)

TERMS: 50% due at acceptance of this document, balance due upon delivery of
       Final product.

Accepted: __________________________________  Date: ____________________________
           Kelly Shen -Director Business Technology/ Program Coordinator
 Pfizer Pharmaceuticals

Accepted: __________________________________  Date: ____________________________
           Wayne H. Wertheim
           Executive VP, Medivisor, Inc.


                                       2
EXHIBIT NO. 11

<TABLE>
<CAPTION>

                 Statement re Computation of Per Share Earnings



                  WISCONSIN CENTRAL TRANSPORTATION CORPORATION

                   ($ in thousands, except per share amounts)


                                                                         For the Year Ended
                                                                             December 31,
                                                                --------------------------------------
                                                                1996             1995             1994
                                                                ----             ----             ----

<S>                                                      <C>               <C>               <C>           
Income before extraordinary items ....................   $       50,034    $       44,632    $       38,282

Extraordinary items ..................................           (1,602)           (2,123)           (1,587)
                                                         --------------    --------------    --------------

Net income ...........................................   $       48,432    $       42,509    $       36,695
                                                         ==============    ==============    ==============

Weighted average common shares outstanding:
     Primary .........................................       50,647,000        50,242,000        49,787,000
                                                         ==============    ==============    ==============

     Fully diluted ...................................       51,842,000        51,642,000        50,843,000
                                                         ==============    ==============    ==============

Earnings per common share outstanding - primary:
     Income before extraordinary items ...............   $         0.99    $         0.89    $         0.77
     Extraordinary items .............................            (0.03)            (0.04)            (0.03)
                                                         --------------    --------------    --------------

         Net income ..................................   $         0.96    $         0.85    $         0.74
                                                         ==============    ==============    ==============

Earnings per common share outstanding - fully diluted:
     Income before extraordinary items ...............   $         0.96    $         0.86    $         0.75
     Extraordinary items .............................            (0.03)            (0.04)            (0.03)
                                                         --------------    --------------    --------------

         Net income ..................................   $         0.93    $         0.82    $         0.72
                                                         ==============    ==============    ==============
</TABLE>
October 18, 2012

Michael Guzzetta

Rule Evaluation Section

Emission Assessment Branch

Stationary Source Division

Air Resources Board

P.O. Box 2815

Sacramento, CA 95812

RE: Repeal of Rule 37, Project XL

Dear Mr. Guzzetta:

Enclosed you will find a submittal package regarding the repeal of Ventura County APCD Rule 

37. This rule was repealed by the District Board on June 12, 2012.

The enclosed submittal package includes Completeness Check Lists, the Rule Evaluation Form, 

and various other materials required by EPA Region IX. Please forward this material to EPA, 

Region IX, as a revision to our State Implementation Plan. 

If you have any questions or comments regarding this matter, please contact me at (805) 645-

1408. 

Sincerely

Stan Cowen

Rule Development
OlFF-p^^e^i^'gWAWTOLSTATIONsAyS^^^Sj^TiL"

STATE OF TEXAS ~ ' •---•••

PENALTY FOR

PRIVATE USE

Vj^Sff" '&S?:liSTAGE»RTNEYBOWES

ZIP 78701

02 w

0001401603NOV 05 2015

11/4/2015 :& TUCKER, EDWARD CHARLES^ ^rTCj^b. 241|2005-07-D

The Court has dismissed withoutiwritten^'ord.er thjs subsequent application of habeas corpus. TEX. CODE CR*MgPR©g^rt. 11.07, Sec. 4(a)-(c). -^csszz^^ Abel Acosta, Clerk

WR-74,501-07

for a writ

43B -75-785

EDWARD CHARLES TUCKER w ^

HODGE UNIT - TDC #1495137 ^r

P.O. BOX 999 -ty

RUSK, TX 75785

i/H'fH^lltlllM'liH^IIlW1^!!-1^!!!-!-!"!--*-!*!!!!!!"!!""-!'
#### SELLMAN v. STATE.

No. 20270.

Court of Criminal Appeals of Texas.

March 22, 1939.

Adkins & Adkins, of Brady, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

GRAVES, Judge.

Appellant was convicted of the unlawful possession of whisky for the purpose of sale in a dry area, and fined the sum of $300.

His sole complaint is relative to the sufficiency of the evidence. We find that a search warrant was obtained to search appellant’s filling station on highways Nos. 9 and 16 in McCulloch County, three miles northwest of the town of Brady, and upon a search of such station one pint bottle of whisky was found “back of a cushion used on a settee, and the other pint was back of some lube cans on the shelf.” This witness, A. P. Mercer, testified that he had watched this station at various times immediately prior to this raid; that he had seen numerous people drive into the filling station, and then drive out without buying any gasoline or oil. He further testified that he had seen numerous people drive up in front of the-station and stop, and that either Jim Sell-man or one of the boys would come out to the car, and then go back into the filling station, and come back out in a few minutes and hand to the person in the car a small package about the size of two inches by four inches by eight inches. That such visits to the station were more frequent on the part of young people on occasions when they were having dances in Brady. This testimony was all the testimony introduced by the State.

Appellant offered the testimony of two witnesses which, if believed, would have shown that such whisky was purchased by the witness Huskey for the private use of himself and Jim Sellman on a contemplated fishing trip, the day same was found. That the whisky had been purchased from a negro whose name the witness did not know. Evidently the jury did not believe these witnesses of appellant, and took the State’s theory of this case upon which to predicate its verdict. *495The whisky was found in appellant’s business in places of concealment, and under circumstances that, it seems to us, the jury had the right to refuse to believe that time-worn story of a purchase from an unknown negro that seemed to be so popular a few years ago. See Blankenship v. State, 5 Tex.App. 218; Agleton v. State, 111 Tex.Cr.R. 567, 15 S.W.2d 21; Epple v. State, 112 Tex.Cr.R. 612, 18 S. W.2d 625.

We are of the opinion that the facts are sufficient, and the judgment is affirmed.
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED 9/29/2000
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-30-2001
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               SEP-29-2000
<CASH>                                           3,589
<SECURITIES>                                         0
<RECEIVABLES>                                   27,625
<ALLOWANCES>                                     1,232
<INVENTORY>                                     80,612
<CURRENT-ASSETS>                               117,719
<PP&E>                                          49,979
<DEPRECIATION>                                  20,450
<TOTAL-ASSETS>                                 183,973
<CURRENT-LIABILITIES>                           33,300
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        77,873
<OTHER-SE>                                      70,203
<TOTAL-LIABILITY-AND-EQUITY>                   183,973
<SALES>                                        169,445
<TOTAL-REVENUES>                               169,445
<CGS>                                           97,986
<TOTAL-COSTS>                                   97,986
<OTHER-EXPENSES>                                67,672
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (692)
<INCOME-PRETAX>                                  3,095
<INCOME-TAX>                                     1,269
<INCOME-CONTINUING>                              1,826
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,826
<EPS-BASIC>                                        .13
<EPS-DILUTED>                                      .13


</TABLE>
<TABLE> <S> <C>

<ARTICLE>      5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY RESTATED FINANCIAL INFORMATION FROM
THERMEDICS DETECTION INC.'S  FOR THE PERIOD ENDED JUNE 28, 1997
</LEGEND>
<MULTIPLIER>   1,000
       
<S>                     <C>
<PERIOD-TYPE>                    6-MOS
<FISCAL-YEAR-END>                JAN-03-1998
<PERIOD-END>                     JUN-28-1997
<CASH>                                46,660
<SECURITIES>                               0
<RECEIVABLES>                         17,892
<ALLOWANCES>                           1,463
<INVENTORY>                           17,614
<CURRENT-ASSETS>                      86,130
<PP&E>                                10,043
<DEPRECIATION>                         5,853
<TOTAL-ASSETS>                       149,245
<CURRENT-LIABILITIES>                 43,105
<BONDS>                                    0
<PREFERRED-MANDATORY>                      0
<PREFERRED>                                0
<COMMON>                               1,932
<OTHER-SE>                           104,168
<TOTAL-LIABILITY-AND-EQUITY>         149,245
<SALES>                               43,437
<TOTAL-REVENUES>                      51,171
<CGS>                                 19,147
<TOTAL-COSTS>                         22,802
<OTHER-EXPENSES>                       4,788
<LOSS-PROVISION>                          98
<INTEREST-EXPENSE>                       623
<INCOME-PRETAX>                        8,778
<INCOME-TAX>                           3,511
<INCOME-CONTINUING>                    5,267
<DISCONTINUED>                             0
<EXTRAORDINARY>                            0
<CHANGES>                                  0
<NET-INCOME>                           5,267
<EPS-PRIMARY>                           0.29
<EPS-DILUTED>                           0.29
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the balance
sheets and statements of operations found on pages 2 and 3 of the Company's Form
10-QSB for the year to date, and is qualified in its entirety by reference to
such financial statements.
</LEGEND>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1997
<CASH>                                          29,643
<SECURITIES>                                         0
<RECEIVABLES>                                    9,443
<ALLOWANCES>                                         0
<INVENTORY>                                    149,168
<CURRENT-ASSETS>                               194,946
<PP&E>                                           6,692
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 353,178
<CURRENT-LIABILITIES>                          509,438
<BONDS>                                              0
<COMMON>                                           750
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                    (155,510)
<TOTAL-LIABILITY-AND-EQUITY>                   353,178
<SALES>                                         87,925
<TOTAL-REVENUES>                                87,925
<CGS>                                           24,165
<TOTAL-COSTS>                                   24,165
<OTHER-EXPENSES>                               371,728
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (11,287)
<INCOME-PRETAX>                               (319,255)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (319,255)
<EPS-PRIMARY>                                     (.04)
<EPS-DILUTED>                                        0

</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### Foreign-Trade Zones Board 

          - [Order No. 1129]

                    Pursuant to its authority under the Foreign-Trade Zones Act of June 18, 1934, as amended (19 U.S.C. 81a-81u),                           ( print page 76217)                        the Foreign-Trade Zones Board (the Board) adopts the following Order:                 

*Whereas,*                     the San Francisco Port Commission, grantee of Foreign-Trade Zone 3, submitted an application to the Board for authority to expand FTZ 3 to include the jet fuel storage and distribution system at the San Francisco International Airport and related facilities (261 acres) in the San Francisco, California, area, within the San Francisco Customs port of entry (FTZ Docket 16-2000; filed April 28, 2000);                 

*Whereas,*                     notice inviting public comment was given in the                     **Federal Register**                     (65 FR 30057, May 10, 2000) and the application has been processed pursuant to the FTZ Act and the Board's regulations; and                 

*Whereas,*                     the Board adopts the findings and recommendations of the examiner's report, and finds that the requirements of the FTZ Act and Board's regulations are satisfied, and that the proposal is in the public interest;                 

*Now, Therefore,*                     the Board hereby orders:                 

The application to expand FTZ 3 is approved, subject to the Act and the Board's regulations, including § 400.28. 

Signed at Washington, DC, this 21st day of November 2000. 

Troy H. Cribb, 

Assistant Secretary of Commerce for Import Administration, Alternate Chairman, Foreign-Trade Zones Board.

[FR Doc. 00-31111 Filed 12-5-00; 8:45 am] 

BILLING CODE 3510-DS-P
THIS OPINION HAS NO PRECEDENTIAL VALUE. IT SHOULD NOT BE CITED OR RELIED ON AS PR ECEDENT IN ANY PROCEEDING EXCEPT AS PROVIDED BY RULE 268(d)(2), SCACR.
THE STATE OF SOUTH CAROLINA In The Supreme Court
Julius Powell, Petitioner,

v. State of South Carolina, Respondent. Appellate Case No. 2010-154527
Appeal From Lexington County R. Lawton McIntosh, Post -Conviction Relief Judge L. Casey Manning, Plea Judge
Unpublished Opinion No. 2012-MO-035 Submitted September 5, 2012 – Filed September 12, 2012

AFFIRMED

Tricia A. Blanchette, of Columbia, for Petitioner. Attorney General Alan Wilson, Chief Deputy Attorney General John McIntosh, and Senior Assistant Deputy Attorney General Salley W. E lliott, all of Columbia, for Respondent.

PER CURIAM: Petitioner seeks a writ of certiorari from the denial of his application for post-c onviction relief (PCR).Because there is sufficient evidence to support the PCR judge's finding that petitioner did not knowingly and intelligently wa ive his right to a direct appeal, we grant certiorari as to petitioner's Question I, dispense with further briefing, and proceed with a review of the di rect appeal issue pursuant to Davis v. State , 288 S.C. 290, 342 S.E.2d 60 (1986). The petition fo r a writ of certiorari is denied as to petitioner's Question II.
Petitioner's convictions and sentences are affirmed pur suant to Rule 220(b)(1), SCACR, and the following authorities: State v. McKinney , 278 S.C. 107, 292 S.E.2d 598 (1982) (failure to object at th e plea proceeding that the guilty plea is not knowing and voluntary precludes cons ideration of the issue on appeal).
AFFIRMED. TOAL, C.J., PLEICONES, BEATTY , KITTREDGE and HEARN, JJ., concur.
**EXHIBIT 31.2**

** **

**CERTIFICATIONOFCHIEF FINANCIAL OFFICERDUPONT PHOTOMASKS, INC.**

 

I, Satish Rishi, certify that:

 

1.             I have reviewedthis quarterly report on Form 10-Q of DuPont Photomasks, Inc;

 

2.             Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

 

3.             Based on my knowledge,the financial statements, and other financial information included in thisreport, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, theperiods presented in this report;

 

4.             The registrant’sother certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have:

 

a)  Designed such disclosurecontrols and procedures, or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisreport is being prepared;

 

b)  Evaluated the effectivenessof the registrant’s disclosure controls and procedures and presented in thisreport our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report, based on suchevaluation; and

 

c)  Disclosed in this report anychange in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and

 

5.             The registrant’sother certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (orpersons performing the equivalent functions):

 

a)  All significant deficienciesand material weaknesses in the design or operation of internal control overfinancial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financialinformation; and

 

b)  Any fraud, whether or not material,that involves management or other employees who have a significant role in theregistrant’s internal control over financial reporting.

 
| Date: February 12, 2004 |
|-------------------------|
|                    |
| /s/ SATISH RISHI        |   |
| Satish Rishi            |
| Chief Financial Officer |

 

1

----